Jason P. Hunt

Jason P. Hunt, MD, MS, FACS, serves as Professor and Chair of the Department of Otolaryngology-Head and Neck Surgery at the University of Utah, with adjunct appointments in Neurosurgery. He joined the institution in 2006 and has been instrumental in departmental development, including its transition to a standalone entity. His clinical base is at Huntsman Cancer Institute, where he holds leadership roles including Clinical Director of Head and Neck Surgical Oncology and Medical Director of Operating Rooms. Dr. Hunt specializes in surgical oncology, tumor reconstruction, and thyroid/parathyroid neoplasms.

Education
Dr. Hunt earned foundational training in polymer science (BS/MS, Georgia Tech) before pursuing medicine:

• MD: University of Alabama at Birmingham
• General Surgery Internship: Louisiana State University
• Otolaryngology Residency: Louisiana State University
• Fellowship: Head & Neck Oncologic Surgery/Microvascular Reconstruction, Vanderbilt University

Research Focus
His work spans surgical innovation, cancer biology, and clinical guideline development. Key areas include:

• Thyroid/parathyroid carcinoma pathophysiology and treatment optimization
• Microvascular reconstruction techniques for head/neck defects
• Radiation-induced tissue damage mechanisms
• Quality-of-life outcomes in cancer survivors
• Familial cancer patterns and genetic risk factors

Publication Trends
Dr. Hunt's recent articles (2018–2025) demonstrate a shift toward multidisciplinary approaches: earlier works focused on surgical techniques and genetic epidemiology, while recent publications emphasize guideline development (e.g., NCCN thyroid standards), precision oncology (mutation-based therapies), and pandemic-related survivorship challenges. This reflects integration of molecular biology, patient-centered outcomes, and population health perspectives.

Awards & Honors

• Fellow, American College of Surgeons (FACS)

Clinical & Academic Leadership
He oversees the Head and Neck Cancers Disease Center and mentors surgical trainees. Institutional initiatives under his direction include:

• Expansion of theranostics programs
• Proton therapy center development
• Clinical trials in radioligand therapy